Ethylene

Ethylene

SCHEMBL9950475

C=C.CC(c1ccc(C=O)cc1)C1CCCCC1.CCOC(C)OCC

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.38
CHRM2 P08172 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM3 P20309 1/20 0.37
ALDH1A3 P47895 1/20 0.36
ACHE P22303 6/20 0.35
PTGS2 P35354 6/20 0.35
BCHE P06276 5/20 0.35
ALDH1A1 P00352 2/20 0.34
FFAR1 O14842 1/20 0.33
LMNA P02545 2/20 0.33
GRIA4 P48058 1/20 0.33
MEN1 O00255 1/20 0.32
MITF O75030 1/20 0.32
KMT2A Q03164 1/20 0.32
HTT P42858 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA2A P08913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL9951283 0.89 TYR (0.37) TYRALDH1A3ACHEPTGS2BCHE
Ethylene SCHEMBL9950993 0.88 TYR (0.35) TYRALDH1A3ACHEPTGS2BCHE
Ethylene SCHEMBL9949458 0.88 MEN1 (0.37) TYRCHRM2CHRM1ALDH1A3ACHE
Ethylene SCHEMBL9950389 0.88 TYR (0.36) TYRALDH1A3ACHEPTGS2BCHE
Ethylene SCHEMBL9949858 0.87 ACHE (0.34) TYRALDH1A3ACHEPTGS2BCHE
Ethylene SCHEMBL9951092 0.85 DRD1 (0.34) CHRM2CHRM1CHRM4CHRM5CHRM3
Ethylene SCHEMBL9950142 0.85 TYR (0.35) TYRALDH1A3ACHEPTGS2BCHE
Ethylene SCHEMBL9949874 0.85 TYR (0.33) TYRALDH1A3ACHEPTGS2BCHE
SCHEMBL9950279 0.85 TYR (0.52) TYRCHRM2CHRM1CHRM4CHRM5
Ethylene SCHEMBL9950177 0.84 TYR (0.36) TYRALDH1A3ACHEPTGS2BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2476662-B1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL CO (JP) 2018-05-30 EP claimed
EP-2476662-B1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL CO (JP) 2018-05-30 EP disclosed
US-8748078-B2 Cyclic compound, process for preparation thereof, radiation-sensitive composition, and method for formation of resist pattern MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-06-10 US disclosed
EP-2476662-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN Mitsubishi Gas Chemical Company, Inc. (JP) 2012-07-18 EP disclosed
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN RAD1, RER1, REV1 TYR 4864/4885CHRM2 1034/4885CHRM1 436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.